Basketball star Steven Adams has invested in the NZ brain drink Ārepa. The NBA player has bought 1.44% of the company, saying he was fascinated by the science behind the drink. Ārepa makes nootropics, or brain supplements aimed at increasing cognitive performance for people under pressure and stress. It has just closed its latest capital raising round at NZ$3.2 million, with multiple high-profile investors, including Steven Adams, Zespri chief executive Dan Mathieson and Comvita founder Alan Bougen. Adams says it’s cool to support a company from New Zealand like Ārepa, to see the science behind the product and how it can help people. The company’s drink ingredients included blackcurrants, pine bark and L-theanine, a caffeine-free amino acid found in green tea.